Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
C414305-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$98.90
|
|
|
C414305-5mg
|
5mg |
2
|
$345.90
|
|
|
C414305-10mg
|
10mg |
2
|
$543.90
|
|
|
C414305-25mg
|
25mg |
2
|
$1,224.90
|
|
|
C414305-50mg
|
50mg |
1
|
$1,632.90
|
|
|
C414305-100mg
|
100mg |
1
|
$2,226.90
|
|
E3 Ligase Modulators
| Synonyms | BENZONITRILE, 4-(4-((4-(((2-((3S)-2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1-OXO-1H-ISOINDOL-4-YL)OXY)METHYL)PHENYL)METHYL)-1-PIPERAZINYL)-3-FLUORO- | Benzonitrile, 4-(4-((4-(((2-((3S)-2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1Hisoindol-4-yl)oxy)methyl)phen |
|---|---|
| Specifications & Purity | ≥98% |
| Biochemical and Physiological Mechanisms | CC-92480 is a novel protein degrader and a cereblon E3 ligase modulator (CELMoD) that has anti-myeloma activity. |
| Storage Temp | Store at -20°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
Information CC-92480 CC-92480 is a novel protein degrader and a cereblon E3 ligase modulator (CELMoD) that has anti-myeloma activity. Targets Cereblon In vitro CC-92480 has a unique and rapid degradation profile: the enhanced efficiency to drive the formation of the protein−protein interaction between Aiolos and cereblon, inducing targeted docking to the CRL4-CRBN E3 ubiquitin ligase complex. The CC-92480-dependent binding of Aiolos/Ikaros to CRBN leads to polyubiquitination and ultimately proteasome-mediated degradation of protein. Rapid and extensive loss of Aiolos/Ikaros in sensitive cells, such as multiple myeloma cells, results in apoptosis and subsequent cell death. In vivo CC-92480 is evaluated in efficacy models to assess tumor growth inhibition in tumor bearing mice. When tumors reaches approximately 150 mm3, mice are randomized and treated once daily (q.d.) orally with vehicle control or various dosage strengths of CC-92480. Both the 3 and 10 mg/kg doses give near maximal response in this model, while the lowest dose tested (1 mg/kg) shows 75% reduction in tumor volume by the end of the study. Cell Research(from reference) Cell lines:H929 R10-1 cells Concentrations:1 nM, 10 nM, 100 nM Incubation Time:4 h, 72 h |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Diazinanes |
| Subclass | Piperazines |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Phenylpiperazines |
| Alternative Parents | N-arylpiperazines Isoindolones Alpha amino acids and derivatives Piperidinediones Phenylmethylamines Dialkylarylamines Benzylamines Benzonitriles Aniline and substituted anilines N-alkylpiperazines Fluorobenzenes Delta lactams Aralkylamines Alkyl aryl ethers N-acyl amines Tertiary carboxylic acid amides Pyrrolines N-unsubstituted carboxylic acid imides Dicarboximides Trialkylamines Vinyl fluorides Nitriles Fluoroalkenes Enamines Azacyclic compounds Organopnictogen compounds Organofluorides Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | N-arylpiperazine - Phenylpiperazine - Isoindolone - Alpha-amino acid or derivatives - Isoindole or derivatives - Isoindoline - Aniline or substituted anilines - Dialkylarylamine - Tertiary aliphatic/aromatic amine - Piperidinedione - Phenylmethylamine - Benzylamine - Benzonitrile - Aralkylamine - N-alkylpiperazine - Piperidinone - Halobenzene - Fluorobenzene - Delta-lactam - Alkyl aryl ether - Benzenoid - Piperidine - N-acyl-amine - Monocyclic benzene moiety - Tertiary carboxylic acid amide - Pyrroline - Carboxylic acid imide, n-unsubstituted - Dicarboximide - Carboxylic acid imide - Tertiary aliphatic amine - Tertiary amine - Lactam - Carboxamide group - Amino acid or derivatives - Azacycle - Fluoroalkene - Haloalkene - Vinyl halide - Vinyl fluoride - Nitrile - Carbonitrile - Ether - Enamine - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organofluoride - Organohalogen compound - Amine - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as phenylpiperazines. These are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. |
| External Descriptors | Not available |
|
|
|
| ALogP | 3.586 |
|---|---|
| hba_count | 4 |
| HBD Count | 1 |
| Rotatable Bond | 7 |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Pubchem Sid | 504773496 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504773496 |
| IUPAC Name | 4-[4-[[4-[[2-[(3S)-2,6-dioxopiperidin-3-yl]-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]piperazin-1-yl]-3-fluorobenzonitrile |
| INCHI | InChI=1S/C32H30FN5O4/c33-26-16-23(17-34)8-9-27(26)37-14-12-36(13-15-37)18-21-4-6-22(7-5-21)20-42-29-3-1-2-24-25(29)19-38(32(24)41)28-10-11-30(39)35-31(28)40/h1-9,16,28H,10-15,18-20H2,(H,35,39,40)/t28-/m0/s1 |
| InChIKey | YTINZZFBHWSAGL-NDEPHWFRSA-N |
| Smiles | C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCN(CC5)C6=C(C=C(C=C6)C#N)F |
| Isomeric SMILES | C1CC(=O)NC(=O)[C@H]1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCN(CC5)C6=C(C=C(C=C6)C#N)F |
| Molecular Weight | 567.61 |
| Reaxy-Rn | 33912402 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=33912402&ln= |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 | |
| Certificate of Analysis | Jul 10, 2023 | C414305 |
| Solubility | Solubility (25°C) In vitro DMSO: 100 mg/mL (176.17 mM); Water: Insoluble; Ethanol: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 100 |
| DMSO(mM) Max Solubility | 176.177304839591 |
| Water(mg / mL) Max Solubility | <1 |
| Molecular Weight | 567.600 g/mol |
| XLogP3 | 2.900 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 567.228 Da |
| Monoisotopic Mass | 567.228 Da |
| Topological Polar Surface Area | 106.000 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 1050.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
Starting at $241.90